Opinion
Published on 21 Feb 2022
Repurposing of Antibiotics: Sense or Non-sense
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.833005
- 4,875 views
- 9 citations
Type at least 3 characters
2,015 articles
Articles
Original Research
Published on 18 Feb 2022
Cost-Utility Analysis of Once-Weekly Semaglutide, Dulaglutide, and Exenatide for Type 2 Diabetes Patients Receiving Metformin-Based Background Therapy in China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.831364
- 6,024 views
- 7 citations
Original Research
Published on 18 Feb 2022
Magnetic Resonance Imaging Quantification of the Liver Iron Burden and Volume Changes Following Treatment With Thalidomide in Patients With Transfusion-Dependent ß-Thalassemia
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.810668
- 2,351 views
- 5 citations
Original Research
Published on 18 Feb 2022
The Impact of a National Stewardship Policy on the Usage Patterns of Key Monitoring Drugs in a Tertiary Teaching Hospital: An Interrupted Time Series Analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.847353
- 2,656 views
- 4 citations
Clinical Trial
Published on 18 Feb 2022
Hengli® Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.840695
- 6,181 views
- 4 citations
Opinion
Published on 17 Feb 2022
Going Electronic: Venturing Into Electronic Monitoring Systems to Increase Hand Hygiene Compliance in Philippine Healthcare
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.843683
- 4,829 views
Original Research
Published on 16 Feb 2022
Accessibility of Essential Medicines for Children in Sichuan Province of China: A Cross-Sectional Study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.828152
- 2,603 views
- 3 citations
Original Research
Published on 15 Feb 2022
Irrational Use of Medicine in the Treatment of Presumptive Asthma Among Rural Primary Care Providers in Southwestern China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.767917
- 6,243 views
- 6 citations
Original Research
Published on 14 Feb 2022
Antibiotic Use in China’s Public Healthcare Institutions During the COVID-19 Pandemic: An Analysis of Nationwide Procurement Data, 2018–2020
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.813213
- 10,081 views
- 32 citations
Review
Published on 14 Feb 2022
Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.774170
- 19,417 views
- 28 citations
Systematic Review
Published on 11 Feb 2022
Non-Vitamin K Oral Anticoagulant After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.755009
- 5,706 views
- 6 citations
Brief Research Report
Published on 10 Feb 2022
Real World Data in Health Technology Assessment of Complex Health Technologies
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.837302
- 10,397 views
- 25 citations
Systematic Review
Published on 09 Feb 2022
Additional Use of Prostacyclin Analogs in Patients With Pulmonary Arterial Hypertension: A Meta-Analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.817119
- 3,619 views
- 4 citations
Clinical Trial
Published on 09 Feb 2022
Impact of Pharmacist-Led Diabetes Self-Care Education on Patients With Type 2 Diabetes in Pakistan: A Randomized Controlled Trial
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.754999
- 4,110 views
- 9 citations
Original Research
Published on 09 Feb 2022
Verification of the Usefulness of an Assessment and Risk Control Sheet that Promotes Management of Cancer Drug Therapy
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.744916
- 1,677 views
- 1 citation
Original Research
Published on 09 Feb 2022
Sintilimab Plus Bevacizumab Biosimilar Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.778505
- 4,158 views
- 20 citations